Researchers described single-cell proteogenomics analyses, transcriptome-wide analyses of FACS-purified hematopoietic stem and progenitor cells followed by differential splicing analyses, dual-fluorescence lentiviral splicing reporter assays, and Rebecsinib in pediatric acute myeloid leukemia.
[Cell Reports Medicine]
